This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Laser treatment of myopia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Photorefractive (laser) surgery:

  • used to treat refractive errors such as myopia, astigmatism and hyperopia
  • photorefractive (laser) surgery for the correction of refractive errors is safe and efficacious for use in appropriately selected patients (1)
  • surgical treatments have been developed to improve refraction by re-shaping the cornea
  • corneal re-shaping is achieved using excimer laser ablation. Excimer laser techniques include photorefractive keratectomy (PRK), laser epithelial keratomileusis (LASEK) and laser in situ keratomileusis (LASIK)
    • PRK involves the removal of the corneal epithelium by surgical dissection and excimer laser ablation of a calculated amount of the stromal bed of the cornea
    • LASEK is a modification of PRK; dilute alcohol is used to loosen the corneal epithelium before it is lifted from the treatment zone as a hinged sheet, and then replaced at the end of the procedure
    • in LASIK, a flap is created with a microkeratome; this is lifted before laser ablation and then repositioned

Efficacy of laser surgery:

  • a NICE review states that final uncorrected visual acuity achieved was similar for all three techniques (1)
    • PRK
      • data from more than 2000 eyes treated with PRK for myopia showed that a median of 69% of eyes had achieved within 0.5 D of their intended correction, and that 89% had achieved within 1.0 D
    • LASEK
      • data from case series of more than 1800 eyes undergoing LASEK for myopia or astigmatism showed that a median of 75% of eyes were within 0.5 D and a median of 92% of eyes were within 1.0D of their intended correction at 3–6 months follow-up
    • LASIK
      • data from eyes treated with LASIK for myopia or astigmatism showed that 77% were within 0.5 D and 91% were within 1.0 D of their intended correction at 3–12 months

Safety of laser surgery:

  • loss of two lines of best-spectacle-corrected acuity in eyes treated for myopia
    • PRK
      • a median of 0.5% (0–20.5%)
    • LASEK
      • 0% (0–8.2%) of eyes treated with LASEK
    • LASIK
      • 0.6% (0–3%) of eyes treated with LASIK
    • patients with high myopia were more likely to lose two or more lines of best spectacle-corrected visual acuity than those with moderate to low myopia
  • flap complications
    • may occur during LASIK and LASEK, requiring conversion to PRK or postponement of ablation (with LASIK), and occasionally there may be loss of best spectaclecorrected visual acuity
    • epithelial in-growth has been reported in LASIK ( median of 1.3% (0.0–4.4%)) treated eyes
  • ectasia
    • a condition that can result from corneal thinning, is a serious complication related to refractive surgery that can lead to loss of vision
  • microbial keratitis
    • has been reported in LASIK studies (occurred in 0–0.16% of eyes) - incidence was similar to, or lower than, that reported for contact lens wearers
  • other patient-reported problems included visual difficulty in low light conditions, corneal haze, light halos and problems with glare
    • glare and night vision difficulties were less common after LASIK

Contraindications include (2):

  • unstable myopia e.g. occuring in patients aged under 21 years old
  • patients on steroids
  • keratoconus
  • pregnancy - healing is unpredictable

Reference:

  1. NICE (March 2006). Photorefractive (laser) surgery for the correction of refractive errors
  2. Towler HMA, Lightman S. Ophthalmology. BMJ 1996;312: 889-92

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.